Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Albion VC"


4 mentions found


Venture capitalists need to free up cash and return money to their own investors, known as limited partners (LPs). The secondary share sales market in the US is well established. Bad timingMost VC funds agree to return their profits to their LPs within 10 years. A record 31 secondary funds headquartered in Europe were established in 2021, amid the hype period, with $29 billion in assets under management per PitchBook. It all comes down to how buoyant the VC market is: "If the market is good again, then who's going to sell secondary?
Persons: There's, Michael Smith, Regeneration's Smith, Kelly Rodriques, Hussein Kanji, Kanji, Hussein, Tom Henrikkson, OpeanOcean, it's, Henrikkson Organizations: Venture, Business, Industry Ventures, Cherry Ventures, Ventures, Albion, Forge, Financial Times, VC, Hoxton Ventures, Sequoia Locations: Silicon Valley, Europe, San Francisco, Amsterdam, London
An in-demand talent pool"Many previously poorly understood secrets will be more widely disseminated across the ecosystem," one European AI founder who spoke on the condition of anonymity said. But European competitors can still benefit from OpenAI's implosion. The startup had been on an uninterrupted run for the past year, said EarlyBird VC partner and Aleph Alpha investor Andre Retterath. The turmoil at OpenAI has also galvanized both AI founders and investors in Europe. The company's top expenditure, besides employee salaries, is manually cleaning and sourcing the data they use to train their models, a European VC said.
Persons: Sam Altman, unseats, Nathan Benaich, Altman, Marc Benioff, Salesforce, Silvio Savarese, Einstein, 1RXoc9ekeo, Benaich, Alpha, EarlyBird, Andre Retterath, Retterath, Mariam Pettit, they've, OpenAI, Andrew Scott, 7percent, David Grimm, Grimm, Rebecca Gorman Organizations: Air Street Capital, Business, Aleph Alpha, Microsoft, Google, Alpha, Global Founders Capital, Albion Locations: Europe, OpenAI
Big Pharma and biotech companies often outsource clinical trials to external companies. Europe's early-stage clinical trials startups are flush with funds but they're struggling to grow. The fate — and market cap — of a biotech company often lies with a successful clinical trial. The COVID-19 pandemic also spotlighted another promising alternative to carry out these trials — startups. While the US touts around a dozen clinical trials unicorns valued at $1 billion or higher, per Dealroom estimates, Europe's startups are lagging behind.
Persons: BEN, Janssen, Christoph Ruedig, Maya Zlatanova, Europe hasn't, Matt Wilson, Wilson, Christoph Massner, it's, Ruedig Organizations: Big Pharma, pharma, Janssen Pharmaceuticals, Tempus, Venture, Albion VC, US, Earlybird Ventures Locations: Europe, New York, American
Toqio, a London-based fintech SaaS startup, has raised $19.2 million in Series A funding. The startup's platform enables companies to launch their own fintech products. London-based fintech startup Toqio has raised $19.2 million in fresh funding. Companies can access a range of different banking and embedded finance products from the startup's platform. The startup believes its platform and marketplace offer a more cost-efficient way for companies to launch their own financial products.
Total: 4